OPA3 and optic atrophy: Costeff Syndrome or type III 3-methylglutaconic aciduria (MGA) is a rare neurodegenerative disorder characterised by ataxia, spastic paraplegia, extrapyramidal dysfunction, cognitive deficits and optic atrophy, and it is almost exclusively seen in patients of Iraqi Jewish descent harbouring recessive OPA3 mutations [10].